-transparent.png){kind=logo}
Thirty-nine patients with stage IIIMO non-cell bronchogenic carcinoma (NOBC) were treated with combined modality therapy: radiation therapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, and procarbazine. The median survival for all patients treated was 9.6 months compared to 6.4 months for historical controls (P = 0.015). Patients who responded to the treatment program had a significantly longer survival (median, 15.2 months) compared to nonresponders and historical controls (P less than 0.005). It is concluded that combined modality therapy is moderately effective therapy in stage IIIMO NOBC.
Related Publications
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
July 1988,
International journal of radiation oncology, biology, physics,
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
January 1993,
European journal of cancer (Oxford, England : 1990),
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
July 1978,
Cancer,
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
January 2002,
Cancer journal (Sudbury, Mass.),
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
January 1979,
Cancer clinical trials,
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
July 2010,
Seminars in radiation oncology,
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
January 2006,
The oncologist,
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
September 1977,
Cancer treatment reviews,
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
December 1990,
Hematology/oncology clinics of North America,
J D Bitran, and
R K Desser, and
T DeMeester, and
C M Shapiro, and
A Billings, and
L Rubenstein, and
R Evans, and
M Colman, and
C Y Rao, and
M Griem, and
H M Golomb
December 1990,
Cancer,
